Delivery Order SPE2DB24D2101-SPE2DB25FKPWU
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,545.60 to AmerisourceBergen Drug Corp for Humulin R 500 Unit/mL KwikPen 3mL insulin pens, with an ultimate completion date of August 7, 2025. This non-competitive delivery order represents a firm fixed-price pharmaceutical supply transaction to support federal medical procurement needs. The award was issued on August 6, 2025, with performance to occur at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a $5,099.04 delivery order to AmerisourceBergen Drug Corp for Humulin R 500 Unit/mL KwikPen 3mL insulin pens on September 25, 2025, with completion targeted for September 26, 2025. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order for pharmaceutical supplies to support federal medical procurement needs. The award was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a $18,586.11 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. This is a firm fixed-price delivery order with an ultimate completion date of September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $15,528.32 to AmerisourceBergen Drug Corp for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens. This non-competitive delivery order carries a firm fixed price and is scheduled for completion by September 8, 2025. The award was made to AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania, where the products will be supplied from. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,876.19 to AmerisourceBergen Drug Corp for the supply of Humulin R 500 Unit/mL KwikPen insulin pens (3mL). The contract employs firm fixed price terms and is scheduled for completion by September 19, 2025, one day after the award date of September 18, 2025. This non-set-aside delivery order is being fulfilled from the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $26,828.48 to AmerisourceBergen Drug Corp for Humulin R 500 Unit/ML KwikPen 3ML insulin pens. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 31, 2025, and represents a single transaction under AmerisourceBergen's existing contract vehicle with DLA. The pharmaceutical product will be delivered to the company's distribution center in Conshohocken, Pennsylvania. As a non-set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $4,757.09 to AmerisourceBergen Drug Corp for Humulin R 500 Unit/mL KwikPen 3mL insulin pens, with a completion date of September 19, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The product will be delivered from the awardee's Conshohocken location. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,503.23 for Humulin R 500 Unit/mL KwikPen 3mL insulin pens, with a completion date of September 4, 2025. This competitively awarded, non-set-aside delivery order represents a firm fixed-price transaction for pharmaceutical supply to support federal medical procurement needs. The contract is performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, reflecting the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, valued at $12,000.90. This is a firm fixed price delivery order with no set-aside designation, representing a competitive award. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 16, 2025. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,905.37 to AmerisourceBergen Drug Corp for Humulin R 500 Unit/mL KwikPen 3mL insulin pens, with a completion date of September 25, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded and represents a continuation of pharmaceutical supply under the company's broader federal contract portfolio. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKPWUDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,419.44 to AmerisourceBergen Drug Corp for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. This competitively awarded, firm fixed-price delivery order was issued on September 24, 2025, with an ultimate completion date of September 25, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical procurement supporting federal healthcare needs through AmerisourceBergen's extensive supply chain capabilities. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. This prime pharmaceutical supply contract serves as a comprehensive global vehicle enabling AmerisourceBergen to deliver a wide range of pharmaceutical products and medical supplies to military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other government entities. As a major pharmaceutical distributor headquartered in Pennsylvania and registered in the System for Award Management, AmerisourceBergen demonstrates significant capability in meeting competitive federal medical procurement requirements across multiple therapeutic domains and delivery scales.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 9/24/25 |